Topic

biotech

COEPTIS Completes $10M Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

Insider Brief Coeptis, Inc. has closed an additional $5.7 million in Series A Preferred funding, bringing the total round to $10 million, reinforcing investor confidence in its AI-driven biotechnology and therapeutic solutions. The funding,

11 Feb 2025 · 3 min read

Business & Markets · Startups

Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics

7 Feb 2025

Business & Markets · Startups

Manas AI Closes $24.6M Funding Round to Accelerate Drug Discovery with AI

29 Jan 2025

Policy & Government · Regulation

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

2 Jan 2025

Business & Markets · Startups

Nuritas Secures $42M Series C to Revolutionize Ingredient Discovery and Improve Lives of Billions

28 Dec 2024

Technology & Infrastructure · Applications & agents

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

18 Dec 2024

Technology & Infrastructure · Applications & agents

Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model

16 Dec 2024

biotech

COEPTIS Completes $10M Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics

Manas AI Closes $24.6M Funding Round to Accelerate Drug Discovery with AI

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

Nuritas Secures $42M Series C to Revolutionize Ingredient Discovery and Improve Lives of Billions

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model

Trending today

Guest Post: Catch Me If You Can

Instinct Announces $1B in Series C Funding from Sequoia, Benchmark and Coatue at $10B Valuation

China’s MirrorMe Unveils Viva Dexterous Hand that Performs Human-Robot Piano Duet

PrismML Brings Its 1-Bit Bonsai LLM to Qualcomm-Powered AI Smart Glasses

Nscale Secures $3.36B in Convertible Financing Ahead of NYSE IPO

biotech

COEPTIS Completes $10M Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics

Manas AI Closes $24.6M Funding Round to Accelerate Drug Discovery with AI

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

Nuritas Secures $42M Series C to Revolutionize Ingredient Discovery and Improve Lives of Billions

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model

Trending today

Guest Post: Catch Me If You Can

Instinct Announces $1B in Series C Funding from Sequoia, Benchmark and Coatue at $10B Valuation

China’s MirrorMe Unveils Viva Dexterous Hand that Performs Human-Robot Piano Duet

PrismML Brings Its 1-Bit Bonsai LLM to Qualcomm-Powered AI Smart Glasses

Nscale Secures $3.36B in Convertible Financing Ahead of NYSE IPO

The AI economy, every weekday morning